Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Sep;54(9):771–778. doi: 10.1136/thx.54.9.771

Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome

A Schnabel 1, E Csernok 1, J Braun 1, W Gross 1
PMCID: PMC1745565  PMID: 10456969

Abstract

BACKGROUND—To obtain insight into the mechanisms of tissue injury in lung disease due to Churg-Strauss syndrome (CSS), the bronchoalveolar lavage (BAL) cell profile and the levels in the BAL fluid of cell products released by activated eosinophils and neutrophils were assessed.
METHODS—Thirteen patients with active progressive CSS (n = 7) or CSS in partial remission (n = 6) underwent clinical staging and bronchoalveolar lavage. The levels of eosinophil cationic protein (ECP), myeloperoxidase (MPO), and peroxidase activity in the BAL fluid were determined and the results were compared with those of 19 patients with pulmonary active Wegener's granulomatosis (WG) and nine control subjects.
RESULTS—In patients with progressive CSS the BAL cell profile was dominated by eosinophils, neutrophil elevation being the exception. The eosinophilia was associated with high ECP levels (4.39 ng/ml and 0.40 ng/ml in the two CSS groups compared with unmeasurable values in the controls). Individual patients with highly active CSS also had raised MPO levels, comparable to the levels in the most active WG patients. Peroxidase activity in the BAL fluid was 1.26 U/ml and 0.10 U/ml in the two groups of patients with CSS and 0.20 U/ml in the controls. Pulmonary disease in patients with WG was characterised by an extensive increase in MPO (0.30ng/ml versus 0.13 ng/ml in the controls) together with high peroxidase activity in the BAL fluid (4.37 U/ml), but only a small increase in ECP levels was seen. No correlation was found between the ECP and MPO levels in patients with CSS which suggests that eosinophil and neutrophil activation vary independently of each other.
CONCLUSIONS—These findings suggest that, in addition to eosinophil activation, neutrophil activation is an important feature in some patients with highly active CSS. The balance of neutrophil and eosinophil involvement appears to be variable and this may be one explanation for the individually variable treatment requirements of patients with CSS.



Full Text

The Full Text of this article is available as a PDF (121.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borregaard N., Cowland J. B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997 May 15;89(10):3503–3521. [PubMed] [Google Scholar]
  2. Bousquet J., Chanez P., Lacoste J. Y., Enander I., Venge P., Peterson C., Ahlstedt S., Michel F. B., Godard P. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol. 1991 Oct;88(4):649–660. doi: 10.1016/0091-6749(91)90159-l. [DOI] [PubMed] [Google Scholar]
  3. Braun J., Dalhoff K., Lipp R., Eckmann C., Marre R., Wood W. G., Wiessmann K. J. Myeloperoxidase, Lactoferrin und Elastase in bronchoalveolärer Lavage und Plasma bei Pneumonie. Pneumologie. 1992 Apr;46(4):141–147. [PubMed] [Google Scholar]
  4. Brouwer E., Huitema M. G., Mulder A. H., Heeringa P., van Goor H., Tervaert J. W., Weening J. J., Kallenberg C. G. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994 Apr;45(4):1120–1131. doi: 10.1038/ki.1994.149. [DOI] [PubMed] [Google Scholar]
  5. Cailes J. B., O'Connor C., Pantelidis P., Southcott A. M., Fitzgerald M. X., Black C. M., du Bois R. M. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Eur Respir J. 1996 May;9(5):992–999. doi: 10.1183/09031936.96.09050992. [DOI] [PubMed] [Google Scholar]
  6. Cantin A. M., North S. L., Fells G. A., Hubbard R. C., Crystal R. G. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest. 1987 Jun;79(6):1665–1673. doi: 10.1172/JCI113005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chanez P., Enander I., Jones I., Godard P., Bousquet J. Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int Arch Allergy Immunol. 1996 Sep;111(1):83–88. doi: 10.1159/000237350. [DOI] [PubMed] [Google Scholar]
  8. Gross W. L., Schmitt W. H., Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993 Jan;91(1):1–12. doi: 10.1111/j.1365-2249.1993.tb03345.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999 Jan;78(1):26–37. doi: 10.1097/00005792-199901000-00003. [DOI] [PubMed] [Google Scholar]
  10. Hoffman G. S., Sechler J. M., Gallin J. I., Shelhamer J. H., Suffredini A., Ognibene F. P., Baltaro R. J., Fleisher T. A., Leavitt R. Y., Travis W. D. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis. 1991 Feb;143(2):401–407. doi: 10.1164/ajrccm/143.2.401. [DOI] [PubMed] [Google Scholar]
  11. Hällgren R., Bjermer L., Lundgren R., Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis. 1989 Feb;139(2):373–377. doi: 10.1164/ajrccm/139.2.373. [DOI] [PubMed] [Google Scholar]
  12. Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., Hagen E. C., Hoffman G. S., Hunder G. G., Kallenberg C. G. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187–192. doi: 10.1002/art.1780370206. [DOI] [PubMed] [Google Scholar]
  13. Jennette J. C., Falk R. J. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant. 1998;13 (Suppl 1):16–20. doi: 10.1093/ndt/13.suppl_1.16. [DOI] [PubMed] [Google Scholar]
  14. Lacoste J. Y., Bousquet J., Chanez P., Van Vyve T., Simony-Lafontaine J., Lequeu N., Vic P., Enander I., Godard P., Michel F. B. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993 Oct;92(4):537–548. doi: 10.1016/0091-6749(93)90078-t. [DOI] [PubMed] [Google Scholar]
  15. Lanham J. G., Elkon K. B., Pusey C. D., Hughes G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984 Mar;63(2):65–81. doi: 10.1097/00005792-198403000-00001. [DOI] [PubMed] [Google Scholar]
  16. Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., Calabrese L. H., Fries J. F., Lie J. T., Lightfoot R. W., Jr The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990 Aug;33(8):1101–1107. doi: 10.1002/art.1780330807. [DOI] [PubMed] [Google Scholar]
  17. Masi A. T., Hunder G. G., Lie J. T., Michel B. A., Bloch D. A., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990 Aug;33(8):1094–1100. doi: 10.1002/art.1780330806. [DOI] [PubMed] [Google Scholar]
  18. Mrowka C., Csernok E., Gross W. L., Feucht H. E., Bechtel U., Thoenes G. H. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis. Am J Kidney Dis. 1995 Feb;25(2):253–261. doi: 10.1016/0272-6386(95)90006-3. [DOI] [PubMed] [Google Scholar]
  19. Nölle B., Specks U., Lüdemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989 Jul 1;111(1):28–40. doi: 10.7326/0003-4819-111-1-28. [DOI] [PubMed] [Google Scholar]
  20. Olivieri D., Pesci A., Bertorelli G. Eosinophilic alveolitis in immunologic interstitial lung disorders. Lung. 1990;168 (Suppl):964–973. doi: 10.1007/BF02718234. [DOI] [PubMed] [Google Scholar]
  21. Pohl W. R., Schenk E., Umek H., Micksche M., Kummer F., Köhn H. Aussagekraft der Sekretionsprodukte von Eosinophilen und Neutrophilen in der bronchoalveolären Lavage bei Patienten mit idiopathischer Lungenfibrose. Wien Klin Wochenschr. 1993;105(14):387–392. [PubMed] [Google Scholar]
  22. Riise G. C., Ahlstedt S., Larsson S., Enander I., Jones I., Larsson P., Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax. 1995 Apr;50(4):360–365. doi: 10.1136/thx.50.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rothenberg M. E. Eosinophilia. N Engl J Med. 1998 May 28;338(22):1592–1600. doi: 10.1056/NEJM199805283382206. [DOI] [PubMed] [Google Scholar]
  24. Schmekel B., Karlsson S. E., Linden M., Sundström C., Tegner H., Venge P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation. 1990 Aug;14(4):447–454. doi: 10.1007/BF00914095. [DOI] [PubMed] [Google Scholar]
  25. Schmitt W. H., Csernok E., Kobayashi S., Klinkenborg A., Reinhold-Keller E., Gross W. L. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum. 1998 Mar;41(3):445–452. doi: 10.1002/1529-0131(199803)41:3<445::AID-ART10>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  26. Schnabel A., Holl-Ulrich K., Dalhoff K., Reuter M., Gross W. L. Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J. 1997 Dec;10(12):2738–2743. doi: 10.1183/09031936.97.10122738. [DOI] [PubMed] [Google Scholar]
  27. Segelmark M., Persson B., Hellmark T., Wieslander J. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol. 1997 Apr;108(1):167–174. doi: 10.1046/j.1365-2249.1997.d01-992.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shijubo N., Shigehara K., Hirasawa M., Inuzuka M., Abe S. Eosinophilic cationic protein in chronic eosinophilic pneumonia and eosinophilic granuloma. Chest. 1994 Nov;106(5):1481–1486. doi: 10.1378/chest.106.5.1481. [DOI] [PubMed] [Google Scholar]
  29. Tai P. C., Holt M. E., Denny P., Gibbs A. R., Williams B. D., Spry C. J. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) 1984 Aug 18;289(6442):400–402. doi: 10.1136/bmj.289.6442.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tatsis E., Schnabel A., Gross W. L. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med. 1998 Sep 1;129(5):370–374. doi: 10.7326/0003-4819-129-5-199809010-00004. [DOI] [PubMed] [Google Scholar]
  31. Travis W. D., Hoffman G. S., Leavitt R. Y., Pass H. I., Fauci A. S. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol. 1991 Apr;15(4):315–333. doi: 10.1097/00000478-199104000-00001. [DOI] [PubMed] [Google Scholar]
  32. Wallaert B., Gosset P., Prin L., Bart F., Marquette C. H., Tonnel A. B. Bronchoalveolar lavage in allergic granulomatosis and angiitis. Eur Respir J. 1993 Mar;6(3):413–417. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES